Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fish oil + flaxseed oil is a dietary supplement combination that provides essential fatty acids from both marine and plant sources. Fish oil is rich in the long-chain omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which have well-established roles in supporting cardiovascular health, reducing inflammation, and improving lipid profiles. Flaxseed oil contains alpha-linolenic acid (ALA), a plant-based omega-3 fatty acid that can be partially converted to EPA and DHA in the body, though this conversion is limited. The combination aims to deliver a broader spectrum of omega-3s for heart health, anti-inflammatory effects, cholesterol management, and general wellness. This blend may be marketed as "omega 3 6 9" when other oils are added but can exist as just fish oil plus flaxseed oil[1][5][3]. These supplements are not suitable for vegans or vegetarians due to the inclusion of fish-derived ingredients[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fish oil + flaxseed oil.